Related Experiment Video
Updated: Aug 11, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
Published on: September 14, 2010
[Kaposi's sarcoma]
1Hôpital Antoine-Béclère, 157, rue de la Porte-de-Trivaux, 92141 Clamart.
Abstract:
Kaposi's sarcoma (SK) is a cutaneous disease mostly affecting elderly men of Mediterranean ancestry, people from sud-Saharan Africa and HIV infected patients. It is a proliferation of spindle cells. It's neoplastic origin remains controversial. Infection with a gamma herpes virus HHV8 is necessary for the development of KS. In organ recipient patients KS is observed and seems to be related to immune deficiency. In HIV infected patients an effect of HIV as a promoter on KS is added to immune deficiency. Half of HIV-HHV8 co-infected patients may develop KS. Therapeutic management of HIV infected KS patients is primarily to treat HIV infection. This treatment contributed to a dramatic decrease of KS incidence in developed countries. When antiretroviral treatment failed, conventional chemotherapy can be used. New therapies taking in count the complex mechanisms of the KS genesis are under evaluation.
Insights
Kaposi's sarcoma (KS) is a skin cancer linked to human herpesvirus 8 (HHV-8). Treating HIV infection significantly reduces KS incidence in co-infected patients.
Area of Science:
- Oncology
- Virology
- Immunology
Context:
- Kaposi's sarcoma (KS) is a vascular tumor often affecting immunocompromised individuals.
- It is strongly associated with human herpesvirus 8 (HHV-8) infection.
- KS incidence is notably high in HIV-infected populations and organ transplant recipients.
Purpose:
- To review the epidemiology, pathogenesis, and management of Kaposi's sarcoma.
- To highlight the crucial role of HIV and HHV-8 co-infection in KS development.
- To discuss current and emerging therapeutic strategies for KS.
Summary:
- Kaposi's sarcoma (KS) is a neoplastic proliferation of spindle cells, necessitating HHV-8 infection for its development.
- Immune deficiency, particularly in HIV-infected individuals, significantly promotes KS.
- Effective management of HIV infection has dramatically decreased KS incidence, with chemotherapy as a fallback option.
Impact:
- Antiretroviral therapy for HIV has proven highly effective in reducing KS prevalence.
- Understanding KS pathogenesis is key to developing novel targeted therapies.
- Further research into complex KS mechanisms may lead to improved treatment outcomes.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cytomegalovirus Disease
Leishmaniasis
Cryptococcal Meningitis

